MSI-H tumors, which account for approximately 15% of localized colorectal cancer cases, are characterized by dMMR resulting from mutations or epigenetic silencing of key DNA repair genes such as MLH1, MSH2, MSH6, or PMS2 [1-3]. The gene discussed is PMS2; the disease is colorectal cancer.